Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 385 publications
Metachronous Contralateral Recurrence in Upper Tract Urothelial Carcinoma: A Multi-Institutional Competing-Risks Analysis From the ROBUUST 3.0 Registry.
Journal: Urology practice
Published: June 22, 2026
Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 27, 2026
Development and validation of a computational histology artificial intelligence-powered prognostic biomarker in muscle-invasive bladder cancer.
Journal: Urologic oncology
Published: May 18, 2026
Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease.
Journal: Clinical genitourinary cancer
Published: May 07, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry.
Journal: Minerva urology and nephrology
Published: April 23, 2026
Circulating Tumor DNA as a Novel Indicator of Teratoma in Nonseminomatous Germ Cell Tumor.
Journal: Clinical genitourinary cancer
Published: March 22, 2026
Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration): Erratum.
Journal: The Journal of urology
Published: January 09, 2026
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 09, 2026
Identification of High-Performing Safety Net Hospitals for Radical Cystectomy: Implications for National Cancer Institute Cancer Center Partnership.
Journal: JCO oncology practice
Published: January 06, 2026
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry.
Journal: Minerva urology and nephrology
Published: December 18, 2025
Last Updated: 09/26/2026